10X Genomics Inc

NASDAQ TXG

Download Data

10X Genomics Inc Retention Ratio 3 year CAGR for the quarter ending June 30, 2019

10X Genomics Inc Retention Ratio 3 year CAGR is NA for the quarter ending June 30, 2019. The retention ratio, also known as the plowback ratio, measures the proportion of a company's earnings that are retained after paying dividends. It is calculated by dividing the net income minus dividends paid by the net income. This ratio indicates the percentage of earnings that are reinvested back into the company rather than being distributed to shareholders as dividends. A higher retention ratio suggests a higher level of reinvestment, indicating potential future growth opportunities. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
NASDAQ: TXG

10X Genomics Inc

CEO Dr. Serge Saxonov Ph.D.
IPO Date Sept. 12, 2019
Location United States
Headquarters 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
Employees 1,259
Sector Healthcare
Industry Health information services
Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Similar companies

TWST

Twist Bioscience Corp

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email